World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J.
Am J Hematol. 2024 May;99(5):946-968. doi: 10.1002/ajh.27287. Epub 2024 Mar 29.
[Chronic neutrophilic leukemia/chronic eosinophilic leukemia].
Kawashima I, Kirito K.
Rinsho Ketsueki. 2023;64(10):1326-1334. doi: 10.11406/rinketsu.64.1326.
Hypereosinophilic Syndrome.
Curtis C, Ogbogu P.
Clin Rev Allergy Immunol. 2016 Apr;50(2):240-51. doi: 10.1007/s12016-015-8506-7.
Chronic eosinophilic leukemia/hypereosinophilic syndrome.
Gotlib J.
Cancer Treat Res. 2008;142:69-106.
Chronic Eosinophilic Leukemia Presenting as Cardiac Failure.
Boi-Doku Pepra-Ameyaw N, Ghunney WK, Baafi Ampofo E, Olayemi E.
Case Rep Hematol. 2022 Dec 16;2022:7841310. doi: 10.1155/2022/7841310. eCollection 2022.
Chronic Eosinophilic Leukemia Positive for FIP1L1-PDGFRa.
Haydon SJ, Ross DE, Caucci S, Clark S, Hrinczenko B.
Cureus. 2025 Feb 24;17(2):e79548. doi: 10.7759/cureus.79548. eCollection 2025 Feb.
[FIP1L1::PDGFRA-positive chronic eosinophilic leukemia showing slowly progressive cardiac impairment].
Shimizu M, Kuroda A, Suyama T, Seki M, Shinagawa A.
Rinsho Ketsueki. 2022;63(12):1648-1652. doi: 10.11406/rinketsu.63.1648.
The Molecular Features of Chronic Eosinophilic Leukemia, Not Otherwise Specified.
Qu S, Liu N, Sun Q, Wang H, Jia Y, Qin T, Xu Z, Li B, Pan L, Gao Q, Jiao M, Xiao Z.
Am J Hematol. 2025 May;100(5):928-932. doi: 10.1002/ajh.27645. Epub 2025 Feb 25.
The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Wang SA, Orazi A, Gotlib J, Reiter A, Tzankov A, Hasserjian RP, Arber DA, Tefferi A.
Am J Hematol. 2023 Aug;98(8):1286-1306. doi: 10.1002/ajh.26966. Epub 2023 Jun 7.
Charcot-Leyden crystals in chronic eosinophilic leukemia.
Sandberg Y, Weerkamp F.
Blood. 2021 Apr 8;137(14):1985. doi: 10.1182/blood.2020010648.
